Key result
Norepinephrine infusion over 3 months in dogs increased beta-receptor numbers twofold to threefold in the ventricles and septum, and increased adenylate cyclase sensitivity in the septum.
Why the study?
Does long-term norepinephrine infusion alter beta-adrenergic receptors and cyclic AMP in the canine ventricular septum?
Does long-term norepinephrine infusion alter beta-adrenergic receptors and cyclic AMP in the canine ventricular septum?
Long-term norepinephrine infusion in dogs alters the myocardial adrenergic system, suggesting that depleted cyclic AMP and/or ATP may be involved in the development of hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for adrenergic signaling in canine hypertrophy models; leaves open relevance to human cardiomyopathy.
Norepinephrine infusion in dogs has been shown to cause ventricular septal hypertrophy that mimics the syndrome of hypertrophic cardiomyopathy in humans. To characterize the mechanisms involved in septal hypertrophy, the adrenergic system of the right and left ventricles and the septum were analyzed before and after norepinephrine infusion. In the normal unperturbed state, the septum was found to be more sensitive to beta-adrenergic stimulation than either the right or left ventricles. That is, more cyclic AMP could be generated with a smaller dose of beta-agonist (isoproterenol) in septal tissue homogenate than in homogenates of the right or left ventricles. With infusions of norepinephrine (1.4 micrograms/min) to subhypertensive levels over 3 months, beta-receptor number increased twofold to threefold in the ventricles and septum. Adenylate cyclase activity also increased in the ventricles, but not in the septum. The sensitivity of adenylate cyclase to beta-agonist stimulation increased in the septum but remained unchanged in the right and left ventricles. We conclude that the alterations in the myocardial adrenergic system occur in response to the norepinephrine infusion and are not a consequence of hypertrophy. We formulated a hypothesis suggesting that depleted tissue stores of cyclic AMP and/or adenosine triphosphate may be one of the mechanisms involved in the development of hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Raum et al. (1983) studied Hypertrophic cardiomyopathy. Norepinephrine infusion vs. Normal unperturbed state (baseline) was evaluated on Beta-receptor number and adenylate cyclase activity. Norepinephrine infusion over 3 months in dogs increased beta-receptor numbers twofold to threefold in the ventricles and septum, and increased adenylate cyclase sensitivity in the septum.
Synapse has enriched 10 related papers. Consider them for comparative context: